- Trials with a EudraCT protocol (31)
- Paediatric studies in scope of Art45 of the Paediatric Regulation (1)
31 result(s) found for: Tricyclic Antidepressants.
Displaying page 1 of 2.
EudraCT Number: 2009-015165-31 | Sponsor Protocol Number: EME-08/43/39 | Start Date*: 2010-07-16 |
Sponsor Name:Northumberland, Tyne and Wear NHS Foundation Trust | ||
Full Title: Antiglucocorticoid augmentation of antiDepressants in Depression: a double-blind, randomised, placebo-controlled, parallel-group trial | ||
Medical condition: depression | ||
Disease: | ||
Population Age: Adults | Gender: Male, Female | |
Trial protocol: GB (Completed) | ||
Trial results: View results |
EudraCT Number: 2014-001959-24 | Sponsor Protocol Number: BoTN-Study | Start Date*: 2014-08-26 |
Sponsor Name:University Hospital Essen | ||
Full Title: BoTN: Onabotulinumtoxin A for the treatment of trigeminal neuralgia: Efficacy, safety and neurophysiological alterations under therapy – a prospective, controlled trial | ||
Medical condition: Trigeminal neuralgia | ||
Disease: | ||
Population Age: Adults | Gender: Male, Female | |
Trial protocol: DE (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2005-003251-13 | Sponsor Protocol Number: D1449L00002 | Start Date*: 2005-10-20 |
Sponsor Name:AstraZeneca UK Ltd | ||
Full Title: Quetiapine Augmentation In Treatment-Resistant Depression – An Open Pilot Study | ||
Medical condition: Depression | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: GB (Completed) | ||
Trial results: View results |
EudraCT Number: 2009-011254-18 | Sponsor Protocol Number: AEG33773-201 | Start Date*: 2009-10-02 | |||||||||||
Sponsor Name:Aegera Therapeutics Inc. | |||||||||||||
Full Title: A Multicenter, Randomized, Double-Blind, Placebo-Controlled Study Comparing the Safety and Efficacy of AEG33773 versus Placebo in Patients with Painful Diabetic Peripheral Neuropathy | |||||||||||||
Medical condition: Painful diabetic peripheral neuropathy | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: BG (Completed) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2015-004702-42 | Sponsor Protocol Number: RG101-04 | Start Date*: 2016-01-15 | ||||||||||||||||
Sponsor Name:Regulus Therapeutics Inc. | ||||||||||||||||||
Full Title: A Multi-Center, Parallel Group, Open-Label, Phase 2 Study to Evaluate the Efficacy and Safety of a Single Subcutaneous Injection of RG-101 Combined with Oral GSK2878175 Taken Once Daily for 6, 9, o... | ||||||||||||||||||
Medical condition: Treatment Naïve, Genotype 1 and 3, Chronic Hepatitis C Patients | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | |||||||||||||||||
Trial protocol: HU (Completed) GR (Completed) ES (Completed) | ||||||||||||||||||
Trial results: (No results available) |
EudraCT Number: 2020-005037-32 | Sponsor Protocol Number: PSIKET_002CZE | Start Date*: 2021-09-22 | |||||||||||
Sponsor Name:Národní ústav duševního zdraví | |||||||||||||
Full Title: Psilocybin - a strategy of rapid antidepressant response in depression comorbid with cancer, a randomized double-blind study with the possibility of entering open extension. | |||||||||||||
Medical condition: Depressive disorder comorbid with cancer | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: CZ (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2008-008753-33 | Sponsor Protocol Number: CARISNPP2003 | Start Date*: 2009-04-23 | |||||||||||
Sponsor Name:Janssen Cilag International NV | |||||||||||||
Full Title: A Randomized, Double-Blind, Placebo- and Active-Controlled Study of Carisbamate in the Treatment of Neuropathic Pain in Diabetic Peripheral Neuropathy Followed by a Blinded Extension Phase | |||||||||||||
Medical condition: Neuropathic Pain in Diabetic Peripheral Neuropathy | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: NL (Prematurely Ended) ES (Prematurely Ended) FR (Completed) PT (Prematurely Ended) BE (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2008-007478-39 | Sponsor Protocol Number: 42160443NPP2001 | Start Date*: 2009-10-07 | |||||||||||||||||||||
Sponsor Name:Janssen Cilag International, NV | |||||||||||||||||||||||
Full Title: A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Dose-Ranging Study to Evaluate the Efficacy, Safety, and Tolerability of JNJ-42160443 in Subjects With Postherpetic Neuralgia and Post-T... | |||||||||||||||||||||||
Medical condition: Postherpetic Neuralgia and Post-Traumatic Neuralgia | |||||||||||||||||||||||
|
|||||||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||||||||||||
Trial protocol: BE (Completed) NL (Prematurely Ended) ES (Completed) | |||||||||||||||||||||||
Trial results: View results |
EudraCT Number: 2015-001535-21 | Sponsor Protocol Number: RG101-02 | Start Date*: 2015-07-14 | ||||||||||||||||
Sponsor Name:Regulus Therapeutics Inc. | ||||||||||||||||||
Full Title: A Randomized, Multi-Center, Phase 2 Study to Evaluate Safety and Efficacy of Subcutaneous Injections of RG-101 in Combination with Oral Agents in Treatment Naïve, Genotype 1 and 4, Chronic Hepatiti... | ||||||||||||||||||
Medical condition: Treatment Naïve, Genotype 1 and 4, Chronic Hepatitis C Patients | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | |||||||||||||||||
Trial protocol: HU (Completed) GR (Completed) | ||||||||||||||||||
Trial results: (No results available) |
EudraCT Number: 2006-004007-19 | Sponsor Protocol Number: AV-007-IM | Start Date*: 2006-11-16 | |||||||||||
Sponsor Name:Nycomed Austria GmbH | |||||||||||||
Full Title: A multi-centre, double-blind, placebo-controlled, randomised, parallel group clinical trial to evaluate efficacy and safety of Actovegin® in diabetic type 2 patients with symptomatic diabetic perip... | |||||||||||||
Medical condition: Diabetic Polyneuropathy | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Male, Female | ||||||||||||
Trial protocol: AT (Prematurely Ended) | |||||||||||||
Trial results: View results |
EudraCT Number: 2004-003913-18 | Sponsor Protocol Number: CSAB378A2201 | Start Date*: 2005-08-04 |
Sponsor Name:Novartis Pharma Services AG | ||
Full Title: A multicenter, double-blind, randomized, placebo-controlled, parallel-group study to evaluate the safety and efficacy of SAB378 (15 mg t.i.d.) administered orally for 4 weeks to patients with posth... | ||
Medical condition: Postherpetic neuralgia (PHN) | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: GB (Completed) SE (Completed) DE (Completed) | ||
Trial results: View results |
EudraCT Number: 2015-002578-20 | Sponsor Protocol Number: ESN364_HF_204 | Start Date*: 2015-08-25 | |||||||||||
Sponsor Name:Euroscreen S.A | |||||||||||||
Full Title: Pilot/Phase IIa Trial to Investigate the Effect of ESN364 in Early Postmenopausal Women Suffering From Hot Flashes | |||||||||||||
Medical condition: hot flashes | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Female | ||||||||||||
Trial protocol: BE (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2011-001202-99 | Sponsor Protocol Number: CNSB015CP01 | Start Date*: 2011-10-18 | |||||||||||
Sponsor Name:Relevare Pharmaceuticals, Ltd. | |||||||||||||
Full Title: A Phase IIb/III, Double-Blind, Placebo-Controlled, Randomized Study Investigating the Safety, Tolerability and Efficacy of Flupirtine as Adjunct to Opioids When Administered to Cancer Subjects Who ... | |||||||||||||
Medical condition: Pain with neuropathic features in cancer subjects which is inadequately controlled despite optimized opioid treatment | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: DE (Completed) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2015-002571-24 | Sponsor Protocol Number: 15/0118 | Start Date*: 2016-10-14 |
Sponsor Name:Joint Research Office | ||
Full Title: A Phase IIA Prospective, Single-Centre, Open Label Clinical Trial to Evaluate the Safety, Tolerability and Pharmacodynamic Effects of Ambroxol in Patients with Parkinson Disease: Ambroxol in Diseas... | ||
Medical condition: Parkinson disease | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: GB (Completed) | ||
Trial results: View results |
EudraCT Number: 2009-010091-17 | Sponsor Protocol Number: KIP112967 | Start Date*: 2009-09-15 | |||||||||||
Sponsor Name:GlaxoSmithKline Research & Development Limited | |||||||||||||
Full Title: A randomised, double blind study to evaluate the safety and efficacy of the p38 kinase inhibitor, GW856553, in subjects with neuropathic pain from peripheral nerve injury. Estudio aleatorizado, do... | |||||||||||||
Medical condition: Neuropathic pain | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: ES (Completed) SE (Completed) DK (Completed) GB (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2016-002846-21 | Sponsor Protocol Number: PARENTIDE-02 | Start Date*: 2017-04-10 |
Sponsor Name:BCN Peptides S.A. | ||
Full Title: CLINICAL TRIAL PHASE IIa PROOF OF CONCEPT, DOUBLE BLIND, RANDOMIZED, PLACEBO-CONTROLLED IN PATIENTS WITH NEUROPATHIC PAIN DUE TO PERIPHERAL NERVE INJURY | ||
Medical condition: Patients with neuropathic pain due to peripheral nerve injury | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: ES (Prematurely Ended) | ||
Trial results: View results |
EudraCT Number: 2021-000859-39 | Sponsor Protocol Number: EP-104IAR-201 | Start Date*: 2021-09-01 | |||||||||||
Sponsor Name:Eupraxia Pharmaceuticals Inc. | |||||||||||||
Full Title: A Phase 2, Randomized, Double-Blind, Vehicle-Controlled Study Evaluating the Safety, Efficacy and Pharmacokinetics of Single Dose EP-104IAR for 24 Weeks in Patients with Osteoarthritis of the Knee | |||||||||||||
Medical condition: Osteoarthritis of the knee | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: DK (Completed) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2013-004384-31 | Sponsor Protocol Number: SAG/0211PFC-11S1 | Start Date*: 2015-06-10 | |||||||||||
Sponsor Name:Sucampo AG | |||||||||||||
Full Title: A Multicentre, Long-term Safety, Efficacy and Pharmacokinetics Study of Lubiprostone in Paediatric Subjects Aged ≥6 to <18 years with Functional Constipation | |||||||||||||
Medical condition: functional constipation in paediatric patients | |||||||||||||
|
|||||||||||||
Population Age: Children, Adolescents, Under 18 | Gender: Male, Female | ||||||||||||
Trial protocol: BE (Completed) GB (Completed) DE (Completed) ES (Ongoing) NL (Completed) FR (Ongoing) PL (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2010-022991-29 | Sponsor Protocol Number: SMR/0211OBD-1033 | Start Date*: 2011-02-01 | |||||||||||
Sponsor Name:Sucampo Pharma Americas, Inc. | |||||||||||||
Full Title: A Multicenter, Randomized, Placebo-controlled, Double-blinded Study of the Efficacy and Safety of Lubiprostone in Patients with Opioid-induced Bowel Dysfunction | |||||||||||||
Medical condition: Opioid-induced Bowel Dysfunction | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: GB (Completed) DE (Completed) BE (Completed) SE (Completed) CZ (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2012-002840-26 | Sponsor Protocol Number: PD0005 | Start Date*: 2013-03-05 | |||||||||||
Sponsor Name:UCB Biosciences GmbH | |||||||||||||
Full Title: A Multicenter, Multinational, Double-blind, Placebo-controlled, 3-arm Phase 4 Study to Evaluate the Efficacy of Rotigotine on Parkinson's Disease- Associated Apathy, Motor Symptoms, and Mood | |||||||||||||
Medical condition: Parkinson's disease | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: AT (Completed) ES (Completed) HU (Completed) IT (Completed) BG (Completed) SI (Completed) RO (Completed) SK (Completed) | |||||||||||||
Trial results: View results |
Subscribe to this Search
To subscribe to the RSS feed for this search click here . This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
To subscribe to the RSS feed for this search click here . This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
Download Options: | |
---|---|
Number of Trials to download: | |
Download Content: | |
Download Format: | |
Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial. |
Query did not match any studies.